Amazon’s RxPass doesn’t yet really compete with Mark Cuban’s Cost Plus Drug Company

Forbes

3 February 2023 - Amazon is adding RxPass to its pharmacy footprint. Purportedly, it’s competing with Mark Cuban’s Cost Plus Drug Company. 

But, limitations suggest it isn’t yet a real competitor.

Read Forbes article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pharmacy , Supply